Projected Mitigation of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B in the Gray Zone and the Immune-Tolerant Phase in the United States

By sjmartinez • February 21, 2025

Pak K, Sachar R, Saab S. Projected Mitigation of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B in the Gray Zone and the Immune-Tolerant Phase in the United States. Dig Dis Sci. 2025 Feb 20. doi: 10.1007/s10620-025-08909-z. Epub ahead of print. PMID: 39979574.

Tags: Digestive Diseases, Gray zone, HCC, hepatitis B, Immune-tolerant, Publications

Recurrent Barrett’s esophagus-related neoplasia is uncommon after successful endoscopic eradication therapy over long-term follow-up

Enke T, Pokala SK, Hensen C, Brennan C, Gallegos J, Hochheimer CJ, Muthusamy VR, Thaker AM, Kushnir V, Early D, Rastogi A, Hammad H, Edmundowicz[...]

Cardiovascular disease mortality among women diagnosed with de novo metastatic breast cancer

Ramin C, Gresham G, Li J, Karlstaedt A, Hashibe M, Nikolova AP, Atkins KM. Cardiovascular disease mortality among women diagnosed with de novo metastatic breast[...]

Trends in Early-Onset Colorectal Adenocarcinoma and Neuroendocrine Tumors Across Racial and Ethnic Groups

Patel C, Abboud Y, Karkra R, Qureshi I, Gaglio P, Lingiah V, Al-Khazraji A, Hajifathalian K. Trends in Early-Onset Colorectal Adenocarcinoma and Neuroendocrine Tumors Across[...]